ArticleJournal of clinical hypertension (Greenwich, Conn.)2005

The efficacy and safety of low- and high-dose fixed combinations of irbesartan/hydrochlorothiazide in patients with uncontrolled systolic blood pressure on monotherapy: the INCLUSIVE trial.

Joel M Neutel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.